Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear receptor subfamily 1, group H, member 2 | Starlite/ChEMBL | References |
Homo sapiens | nuclear receptor subfamily 1, group H, member 3 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Onchocerca volvulus | Bile acid receptor homolog | Get druggable targets OG5_134445 | All targets in OG5_134445 |
Brugia malayi | ecdysteroid receptor | Get druggable targets OG5_134445 | All targets in OG5_134445 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_134445 | All targets in OG5_134445 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | photoreceptor-specific nuclear receptor | nuclear receptor subfamily 1, group H, member 3 | 387 aa | 321 aa | 28.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0043 | 0.0393 | 0.5 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0192 | 0.7023 | 0.7023 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0393 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0043 | 0.0393 | 0.5 |
Onchocerca volvulus | 0.0111 | 0.343 | 0.4181 | |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0043 | 0.0393 | 0.0393 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0043 | 0.0393 | 0.5 |
Schistosoma mansoni | alpha-glucosidase | 0.0166 | 0.5836 | 0.5836 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0192 | 0.7023 | 1 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0192 | 0.7023 | 0.7023 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0043 | 0.0393 | 0.5 |
Schistosoma mansoni | gabp alpha | 0.0085 | 0.2289 | 0.2289 |
Loa Loa (eye worm) | hypothetical protein | 0.0219 | 0.8204 | 0.8204 |
Brugia malayi | Ets-domain containing protein | 0.0085 | 0.2289 | 0.2289 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0192 | 0.7023 | 1 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0043 | 0.0393 | 0.5 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0043 | 0.0393 | 0.056 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0085 | 0.2289 | 0.326 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0043 | 0.0393 | 0.5 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0043 | 0.0393 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0043 | 0.0393 | 0.5 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0043 | 0.0393 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0192 | 0.7023 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0073 | 0.174 | 0.174 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0085 | 0.2289 | 0.2289 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0043 | 0.0393 | 0.5 |
Schistosoma mansoni | alpha glucosidase | 0.0043 | 0.0393 | 0.0393 |
Trypanosoma brucei | glucosidase, putative | 0.0043 | 0.0393 | 0.5 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0043 | 0.0393 | 0.0393 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0085 | 0.2289 | 0.326 |
Brugia malayi | Ets-domain containing protein | 0.0085 | 0.2289 | 0.2289 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0043 | 0.0393 | 0.5 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0043 | 0.0393 | 0.056 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0043 | 0.0393 | 0.5 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0043 | 0.0393 | 0.5 |
Brugia malayi | ecdysteroid receptor | 0.0219 | 0.8204 | 0.8204 |
Schistosoma mansoni | alpha-glucosidase | 0.0166 | 0.5836 | 0.5836 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0043 | 0.0393 | 0.5 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0219 | 0.8204 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 71 % | Stimulation of [3H]cholesterol efflux in human THP1 foam cells loaded with ac-LDL relative to TO901317 | ChEMBL. | 19962892 |
EC50 (functional) | = 10 nM | Stimulation of [3H]cholesterol efflux in human THP1 foam cells loaded with ac-LDL | ChEMBL. | 19962892 |
EC50 (functional) | = 0.44 uM | Effect on ABCA1 gene expression in human differentiated THP1 cells | ChEMBL. | 19962892 |
EC50 (binding) | = 0.63 uM | Agonist activity at human LXRbeta ligand binding domain expressed in human HuH7 cells co-transfected with Gal4-DBD by transactivation assay | ChEMBL. | 19962892 |
EC50 (functional) | = 1.25 uM | Effect on triglyceride accumulation in human HepG2 cells | ChEMBL. | 19962892 |
EC50 (binding) | = 3 uM | Agonist activity at human LXRalpha ligand binding domain expressed in human HuH7 cells co-transfected with Gal4-DBD by transactivation assay | ChEMBL. | 19962892 |
Efficacy (binding) | = 57 % | Agonist activity at human LXRalpha ligand binding domain expressed in human HuH7 cells co-transfected with Gal4-DBD by transactivation assay relative to T0901317 | ChEMBL. | 19962892 |
Efficacy (functional) | = 68 % | Effect on triglyceride accumulation in human HepG2 cells relative to TO901317 | ChEMBL. | 19962892 |
Efficacy (binding) | = 72 % | Agonist activity at human LXRbeta ligand binding domain expressed in human HuH7 cells co-transfected with Gal4-DBD by transactivation assay relative to T0901317 | ChEMBL. | 19962892 |
Efficacy (functional) | = 107 % | Effect on ABCA1 gene expression in human differentiated THP1 cells relative to TO901317 | ChEMBL. | 19962892 |
IC50 (binding) | = 16 nM | Displacement of [3H]TO901317 from human recombinant LXRbeta expressed in Escherichia coli by flashplate method | ChEMBL. | 19962892 |
IC50 (binding) | = 543 nM | Displacement of [3H]TO901317 from human recombinant LXRalpha expressed in Escherichia coli by flashplate method | ChEMBL. | 19962892 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 19962892 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.